Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Syrian Arab Republic

Syrian Arab Republic: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and was 25.3% in 2021. ▼ Falling

Latest (2021)
25.3%
Change on year
down 6.3%
World rank
57th
of 185 countries
All-time high
32.0%
in 2000
All-time low
25.3%
in 2021
Years of data
22
2000–2021

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Syrian Arab Republic, 2000–2021

01020302000201020212000: 32 %2001: 30.2 %2002: 29.8 %2003: 28.7 %2004: 28.2 %2005: 27.4 %2006: 26.7 %2007: 26.4 %2008: 27.2 %2009: 26.6 %2010: 25.9 %2011: 25.7 %2012: 26 %2013: 26.2 %2014: 26.3 %2015: 26.6 %2016: 26.3 %2017: 26.5 %2018: 26.6 %2019: 26 %2020: 27 %2021: 25.3 %

Source: World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Measured in %.

Analysis

The most recent figure for mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Syrian Arab Republic is 25.3%, measured in 2021. That is the lowest value across all 22 years on record.

Compared with earlier readings it is down 6.3% on the previous year and down 1.6% over ten years.

Over the whole period, mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Syrian Arab Republic peaked at 32.0% in 2000 and was at its lowest, 25.3%, in 2021.

Syrian Arab Republic ranks 57th of 185 countries on this measure, in the middle of the range.

The long-run direction has been consistently falling across the 22 years of available data.

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Syrian Arab Republic, year by year

Annual values for Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%) in Syrian Arab Republic, 2000 to 2021.
Year % Change
2000 32.0%
2001 30.2% -5.6%
2002 29.8% -1.3%
2003 28.7% -3.7%
2004 28.2% -1.7%
2005 27.4% -2.8%
2006 26.7% -2.6%
2007 26.4% -1.1%
2008 27.2% +3.0%
2009 26.6% -2.2%
2010 25.9% -2.6%
2011 25.7% -0.8%
2012 26.0% +1.2%
2013 26.2% +0.8%
2014 26.3% +0.4%
2015 26.6% +1.1%
2016 26.3% -1.1%
2017 26.5% +0.8%
2018 26.6% +0.4%
2019 26.0% -2.3%
2020 27.0% +3.8%
2021 25.3% -6.3%

Syrian Arab Republic compared with similar countries

  • Syrian Arab Republic's 25.3% is below the median for low income countries, which is 25.9%, 98% of the median. (25 countries reporting)
  • Syrian Arab Republic's 25.3% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 15.0%, 1.7× the median. (23 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2000s 28.3% 26.4% 32.0% 10
2010s 26.2% 25.7% 26.6% 10
2020s 26.1% 25.3% 27.0% 2

Countries ranked near Syrian Arab Republic

  1. 55 Burkina Faso 25.9% compare
  2. 56 South Sudan 25.5% compare
  3. 57 Cameroon 25.3% compare
  4. 59 Kyrgyzstan 25.0% compare
  5. 59 Uganda 25.0% compare

See the full ranking of 232 places →

More health data for Syrian Arab Republic

All data for Syrian Arab Republic →

Frequently asked questions

What is mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Syrian Arab Republic?
Mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Syrian Arab Republic was 25.3% in 2021, according to World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO).
What is the highest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Syrian Arab Republic?
The highest recorded value was 32.0% in 2000.
What is the lowest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Syrian Arab Republic?
The lowest recorded value was 25.3% in 2021.
How does Syrian Arab Republic rank for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
Syrian Arab Republic ranks 57th out of 185 countries with data for 2021.
Is mortality from cvd, cancer, diabetes or crd between exact ages 30 and rising or falling in Syrian Arab Republic?
Over the last ten years it is down 1.6%. The long-run trend across the full record is falling.
Where does this Syrian Arab Republic data come from?
The figures come from World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as part of Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 22 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Syrian Arab Republic. Statizoid, drawing on World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Retrieved 16 September 2026, from https://health.statizoid.com/stat/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-male-percent/syrian-arab-republic/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-male-percent/syrian-arab-republic/">Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Syrian Arab Republic</a> — Statizoid

About this data

Indicator
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%)
Unit
%
Source
World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
232 places, 5,104 data points, 2000–2021
Last refreshed

Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).